Scarica l'app Stockscreener
52.96
0.13%
-0.07
Dopo l'orario di chiusura:
52.96
Precedente Chiudi:
$53.03
Aprire:
$52.31
Volume 24 ore:
961.95K
Relative Volume:
1.04
Capitalizzazione di mercato:
$2.69B
Reddito:
$534.53M
Utile/perdita netta:
$-11.45M
Rapporto P/E:
-219.66
EPS:
-0.2411
Flusso di cassa netto:
$48.28M
1 W Prestazione:
+0.95%
1M Prestazione:
+27.19%
6M Prestazione:
+81.49%
1 anno Prestazione:
+50.67%
Intervallo 1D:
$51.86
$53.66
Intervallo di 1 settimana:
$51.03
$55.72
Portata 52W:
$25.36
$55.72
Atricure Inc Stock (ATRC) Company Profile
Nome
Atricure Inc
Settore
Industria
Telefono
513-755-4100
Indirizzo
7555 INNOVATION WAY, MASON, OH
Compare ATRC vs ISRG, BDX, ALC, RMD, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
52.96 | 2.70B | 534.53M | -11.45M | 48.28M | -0.2411 |
ISRG
Intuitive Surgical Inc
|
360.46 | 124.79B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
176.42 | 48.98B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
66.55 | 33.08B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
219.58 | 31.73B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
32.39 | 29.87B | 29.14B | 1.07B | 1.05B | 1.1956 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-18 | Downgrade | Oppenheimer | Outperform → Perform |
| 2026-02-11 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-12-17 | Ripresa | JP Morgan | Overweight |
| 2024-04-23 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-10-23 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-09-29 | Iniziato | UBS | Buy |
| 2021-08-05 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Reiterato | Needham | Buy |
| 2020-11-06 | Reiterato | Needham | Buy |
| 2020-04-07 | Iniziato | Oppenheimer | Outperform |
| 2020-02-06 | Iniziato | BTIG Research | Buy |
| 2020-01-24 | Reiterato | Needham | Buy |
| 2019-08-13 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | Iniziato | JP Morgan | Overweight |
| 2018-10-04 | Reiterato | Needham | Buy |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-08-02 | Reiterato | Stifel | Buy |
| 2018-06-18 | Reiterato | Needham | Buy |
| 2018-04-27 | Reiterato | Needham | Buy |
| 2018-01-16 | Reiterato | Needham | Buy |
| 2017-11-02 | Reiterato | Needham | Buy |
| 2017-07-28 | Reiterato | Needham | Buy |
| 2017-05-30 | Ripresa | Piper Jaffray | Overweight |
| 2016-06-30 | Ripresa | JMP Securities | Mkt Outperform |
| 2015-10-28 | Reiterato | Needham | Buy |
| 2015-10-06 | Reiterato | Canaccord Genuity | Buy |
| 2015-10-06 | Reiterato | Needham | Buy |
Mostra tutto
Atricure Inc Borsa (ATRC) Ultime notizie
AtriCure (ATRC) Chief Technical Officer Salvatore Privitera Sells 3,657 Shares - GuruFocus
Do Options Traders Know Something About AtriCure Stock We Don't? - Yahoo Finance
AtriCure CTO Salvatore Privitera sells $201,135 in shares - Investing.com
AtriCure CTO Salvatore Privitera sells $201,135 in shares By Investing.com - Investing.com India
AtriCure (ATRC) CTO discloses pre-set stock sale - Stock Titan
AtriCure, Inc. (ATRC) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
How Atricure Inc. (ATRC) Affects Rotational Strategy Timing - Stock Traders Daily
AtriCure (ATRC) Momentum Meets A Pricey Narrative On $47 Fair Value - simplywall.st
AtriCure CTO Privitera Sells 7,763 Shares at $52.50 Each (NASDAQ: ATRC) - Kalkine Media
AtriCure at Wells Fargo conference: growth and margins run ahead By Investing.com - Investing.com India
AtriCure CTO Salvatore Privitera Sells 7,763 Shares via 10b5-1 Trading Plan - Kalkine Media
Atricure CTO Salvatore Privitera sells $407,557 in stock By Investing.com - Investing.com South Africa
AtriCure Inc (ATRC) Chief Technical Officer Salvatore Privitera Sells 7,763 Shares - GuruFocus
Atricure CTO Salvatore Privitera sells $407,557 in stock - Investing.com
Atricure Insider Sold Shares Worth $407,558, According to a Recent SEC Filing - marketscreener.com
AtriCure (ATRC) CTO sells stock under preset plan - Stock Titan
Biotech Stocks At 52-Week HighsATTO, HALO, IKT, TVTX, ATRC - RTTNews
A Look at AtriCure Inc (ATRC) After 7.5% Gain -- GF Value $39.67 vs Price $52.59 - GuruFocus
ATRC Maintains by Needham -- Price Target Raised to $64.00 - GuruFocus
AtriCure Price Target Raised to $64.00/Share From $45.00 by Needham - Moomoo
Atricure stock hits 52-week high at $50.00 By Investing.com - Investing.com Nigeria
Atricure stock hits 52-week high at $50.00 - Investing.com
Needham raises AtriCure stock price target on trial outlook - Investing.com
Needham raises AtriCure stock price target on trial outlook By Investing.com - Investing.com Nigeria
Trading Systems Reacting to (ATRC) Volatility - Stock Traders Daily
AtriCure (ATRC) Slips 1.48% to $48.54 as Shares Navigate Key Trading RangeVolatility Skew - vinanet.vn
AtriCure Inc. (ATRC) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
AtriCure Inc. (ATRC) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Atrial Fibrillation Surgery Market Companies, Size & Trends 2026-2035 - Precedence Research
ATRC Maintained Overweight by Piper Sandler -- Price Target Rais - GuruFocus
Piper Sandler raises AtriCure stock price target on quality measure By Investing.com - Investing.com Nigeria
Piper Sandler Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $60 - Moomoo
AtriCure chief legal officer sells $458,099 in stock By Investing.com - Investing.com Nigeria
Atricure Insider Sold Shares Worth $458,099, According to a Recent SEC Filing - marketscreener.com
Atrial Fibrillation Treatment Devices Market Trends and Forecast, 2035 | Includes Profiles of Abbott, AtriCure, Boston Scientific, Johnson & Johnson, and Medtronic - Yahoo Finance
AtriCure to Participate in the 2026 Wells Fargo Health Care Conference - Yahoo Finance
BTIG raises AtriCure stock price target on new quality metric By Investing.com - Investing.com Canada
BTIG raises AtriCure stock price target on new quality metric - Investing.com
AtriCure (ATRC) Financial Results: Profit Per Share Clears Its Benchmark in the Latest Session - vinanet.vn
A Look at AtriCure Inc (ATRC) After 3.0% Gain -- GF Value $39.53 vs Price $48.98 - GuruFocus
AtriCure stock hits 52-week high at 48.47 USD By Investing.com - Investing.com Nigeria
AtriCure stock hits 52-week high at 48.47 USD - Investing.com
AtriCure Stock: Promising Cardiovascular Surgical Platform (NASDAQ:ATRC) - Seeking Alpha
Advisors Capital Management LLC Takes Position in AtriCure, Inc. $ATRC - MarketBeat
Bank of America Corp DE Buys 92,830 Shares of AtriCure, Inc. $ATRC - MarketBeat
134,207 Shares in AtriCure, Inc. $ATRC Acquired by Rice Hall James & Associates LLC - MarketBeat
AtriCure (NASDAQ:ATRC) Hits New 52-Week HighTime to Buy? - MarketBeat
Assenagon Asset Management S.A. Buys New Position in AtriCure, Inc. $ATRC - MarketBeat
AllianceBernstein L.P. (ATRC) reports 5.5% beneficial ownership in AtriCure - Stock Titan
AtriCure (ATRC) Is Up 10.1% After Unveiling 2030 Revenue Goal And Trial-Driven Expansion Plans - webull.com
AtriCure Inc. (ATRC) Holds Steady at $43.59 as Range-Bound Trading PersistsTrading Ideas - vinanet.vn
Atricure Inc Azioni (ATRC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
14.67%
2.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):